Ishkripa Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 2.62%
(FY 2022)
- Profit -11.52%
(FY 2022)
- Ebitda 76.66%
(FY 2022)
- Net Worth 71.63%
(FY 2022)
- Total Assets 9.15%
(FY 2022)
About Ishkripa Pharmacy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Arora, Anirudh Arora, Banshi Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U51100UP2019PTC123006
- Company No.
123006
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ishkripa Pharmacy?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Arora  | Director | 05-Nov-2019 | Current |
| Anirudh Arora | Director | 05-Nov-2019 | Current |
| Banshi Arora | Director | 05-Nov-2019 | Current |
| Sumita Arora | Director | 05-Nov-2019 | Current |
Financial Performance of Ishkripa Pharmacy.
Ishkripa Pharmacy Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.62% increase. The company also saw a substantial fall in profitability, with a 11.52% decrease in profit. The company's net worth Soared by an impressive increase of 71.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ishkripa Pharmacy?
Unlock access to Ishkripa Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lucknow Healthcity Trauma Centre And Superspeciality Hospital Private LimitedActive 12 years 1 monthRajesh Arora is a mutual person
- Lucknow Healthcity & Trauma Centre Pharmacy Private LimitedActive 7 years 2 months
Rajesh Arora is a mutual person
- Aastha Stone And Urology Centre Private LimitedActive 2 years 10 months
Anirudh Arora is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ishkripa Pharmacy?
Unlock and access historical data on people associated with Ishkripa Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishkripa Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishkripa Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
